PDHA1 and synovial sarcoma: The multi-component subunit vaccine and multi-epitope vaccine developed according to the conservation and immunoprotective effects of eight candidate antigen proteins (based on the PdhA, Ldh, and MalX proteins) provided positive cross-protection against different strains of SS.